3-hydroxybutyric acid has been researched along with Malignant Melanoma in 4 studies
3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grabacka, M | 1 |
| Plonka, PM | 1 |
| Reiss, K | 1 |
| Luo, Z | 1 |
| Jiang, L | 1 |
| Ding, C | 1 |
| Hu, B | 1 |
| Loh, XJ | 1 |
| Li, Z | 1 |
| Wu, YL | 1 |
| Xia, S | 1 |
| Lin, R | 1 |
| Jin, L | 1 |
| Zhao, L | 1 |
| Kang, HB | 1 |
| Pan, Y | 1 |
| Liu, S | 1 |
| Qian, G | 1 |
| Qian, Z | 1 |
| Konstantakou, E | 1 |
| Zhang, B | 1 |
| Dong, JT | 1 |
| Chung, YR | 1 |
| Abdel-Wahab, O | 1 |
| Merghoub, T | 1 |
| Zhou, L | 1 |
| Kudchadkar, RR | 1 |
| Lawson, DH | 1 |
| Khoury, HJ | 1 |
| Khuri, FR | 1 |
| Boise, LH | 1 |
| Lonial, S | 1 |
| Lee, BH | 1 |
| Pollack, BP | 1 |
| Arbiser, JL | 1 |
| Fan, J | 1 |
| Lei, QY | 1 |
| Chen, J | 1 |
| Rofe, AM | 1 |
| Porter, SJ | 1 |
| Bais, R | 1 |
| Conyers, RA | 1 |
4 other studies available for 3-hydroxybutyric acid and Malignant Melanoma
| Article | Year |
|---|---|
Melanoma-Time to fast or time to feast? An interplay between PPARs, metabolism and immunity.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Animals; Arginine; Cell Nucleus; Humans; Immune System; Immuno | 2020 |
Surfactant Free Delivery of Docetaxel by Poly[(R)-3-hydroxybutyrate-(R)-3-hydroxyhexanoate]-Based Polymeric Micelles for Effective Melanoma Treatments.
Topics: 3-Hydroxybutyric Acid; Animals; Caproates; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Carriers | 2018 |
Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Animals; Cell Proliferation; Dietary Fats; Female; Humans; Hyp | 2017 |
The metabolic response of tumour-bearing mice to fasting.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Adipose Tissue; Animals; Blood Glucose; Fasting; Glucose; Hydr | 1985 |